AU3228689A - New 2,3,4 - substituted imidazoles and 3,4,5 - substituted 1,2,4, - triazoles, the preparation and use thereof - Google Patents

New 2,3,4 - substituted imidazoles and 3,4,5 - substituted 1,2,4, - triazoles, the preparation and use thereof

Info

Publication number
AU3228689A
AU3228689A AU32286/89A AU3228689A AU3228689A AU 3228689 A AU3228689 A AU 3228689A AU 32286/89 A AU32286/89 A AU 32286/89A AU 3228689 A AU3228689 A AU 3228689A AU 3228689 A AU3228689 A AU 3228689A
Authority
AU
Australia
Prior art keywords
substituted
triazoles
preparation
new
imidazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32286/89A
Inventor
Hubert Heuer
Anton Mentrup
Ernst-Otto Renth
Kurt Schromm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU3228689A publication Critical patent/AU3228689A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU32286/89A 1988-03-30 1989-03-30 New 2,3,4 - substituted imidazoles and 3,4,5 - substituted 1,2,4, - triazoles, the preparation and use thereof Abandoned AU3228689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3810848A DE3810848A1 (en) 1988-03-30 1988-03-30 NEW 2,3,4-SUBSTITUTED IMIDAZOLE AND 3,4,5-SUBSTITUTED 1,2,4-TRIAZOLE, THEIR PREPARATION AND USE
DE3810848 1988-03-30

Publications (1)

Publication Number Publication Date
AU3228689A true AU3228689A (en) 1989-10-05

Family

ID=6351100

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32286/89A Abandoned AU3228689A (en) 1988-03-30 1989-03-30 New 2,3,4 - substituted imidazoles and 3,4,5 - substituted 1,2,4, - triazoles, the preparation and use thereof

Country Status (18)

Country Link
EP (1) EP0335381A1 (en)
JP (1) JPH02503679A (en)
KR (1) KR900700459A (en)
AU (1) AU3228689A (en)
DD (1) DD283620A5 (en)
DE (2) DE3810848A1 (en)
DK (1) DK151489A (en)
FI (1) FI891449A (en)
FR (1) FR2629457A1 (en)
GB (1) GB2216890A (en)
HU (1) HUT52091A (en)
IL (1) IL89788A0 (en)
NO (1) NO891293L (en)
PL (1) PL278547A1 (en)
PT (1) PT90142A (en)
WO (1) WO1989009212A1 (en)
YU (1) YU65489A (en)
ZA (1) ZA892259B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927483A1 (en) * 1989-08-19 1991-02-21 Boehringer Ingelheim Kg NEW SUBSTITUTED HETEROCYCLIC FOOT RINGS, THEIR MANUFACTURE AND USE
US5120749A (en) * 1991-02-20 1992-06-09 Abbott Laboratories Platelet activating antagonists
US5155117A (en) * 1991-04-12 1992-10-13 G. D. Searle & Co. 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
DE69232003T2 (en) * 1991-09-18 2002-04-25 Glaxo Group Ltd., Greenford Benzanilide derivatives as 5-HT1D antagonists
WO2004005262A2 (en) 2002-07-02 2004-01-15 Schering Corporation New neuropeptide y y5 receptor antagonists
MXPA04011363A (en) * 2002-07-04 2005-02-14 Aventis Pharma Sa Novel thiophene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use.
US20040192728A1 (en) 2003-02-03 2004-09-30 Ellen Codd Quinoline-derived amide modulators of vanilloid VR1 receptor
WO2006076592A1 (en) 2005-01-14 2006-07-20 Cgi Pharmaceuticals, Inc. 1,3 substituted diaryl ureas as modulators of kinase activity
US7777040B2 (en) 2005-05-03 2010-08-17 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
UY30892A1 (en) 2007-02-07 2008-09-02 Smithkline Beckman Corp AKT ACTIVITY INHIBITORS
EP4242206A1 (en) 2009-01-30 2023-09-13 Novartis AG Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
ES2575215T3 (en) 2009-12-11 2016-06-27 Autifony Therapeutics Limited Imidazolidinedione derivatives
JP5913357B2 (en) 2010-12-06 2016-04-27 アウトイフオンイ トヘラペウトイクス リミテッド Hydantoin derivatives useful as KV3 inhibitors
EP2718285B1 (en) 2011-06-07 2016-03-16 Autifony Therapeutics Limited Hydantoin derivatives as kv3 inhibitors
JP2015517563A (en) 2012-05-22 2015-06-22 アウトイフオンイ トヘラペウトイクス リミテッド Hydantoin derivatives as KV3 inhibitors
JP6240667B2 (en) 2012-05-22 2017-11-29 アウトイフオンイ トヘラペウトイクス リミテッド Triazoles as KV3 inhibitors
US11091447B2 (en) 2020-01-03 2021-08-17 Berg Llc UBE2K modulators and methods for their use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3842089A (en) * 1971-08-18 1974-10-15 Upjohn Co 4-(alpha-(phenyl)-o-toly)-4h-1,2,4-triazoles
GB1378617A (en) * 1972-05-05 1974-12-27 Upjohn Co Triazolylbenzophenones
FR2269938A2 (en) * 1974-05-08 1975-12-05 Delalande Sa 5-Hydroxymethyl-3,4-diphenyl-1,2,4-triazoles - with anticholinergic, bronchodilator, antidepressant, analgesic, vasodilator activity, etc.
FR2539127B1 (en) * 1983-01-10 1985-08-23 Roussel Uclaf NOVEL 4H-1,2,4-TRIAZOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
YU136287A (en) * 1986-07-25 1990-06-30 Boehringer Kg Process for preparing new 1,4 benzodiazepines
FR2813807B1 (en) * 2000-09-14 2002-11-15 Filtrauto GAS FILTER INCLUDING AN ELECTRICAL CIRCUIT AND FILTRATION DEVICE COMPRISING SUCH A FILTER

Also Published As

Publication number Publication date
DE3810848A1 (en) 1989-10-19
GB2216890A (en) 1989-10-18
DK151489A (en) 1989-10-01
PL278547A1 (en) 1990-01-08
FI891449A (en) 1989-10-01
DE3990284D2 (en) 1990-04-05
NO891293D0 (en) 1989-03-28
IL89788A0 (en) 1989-09-28
PT90142A (en) 1989-11-10
KR900700459A (en) 1990-08-13
FR2629457A1 (en) 1989-10-06
HUT52091A (en) 1990-06-28
DD283620A5 (en) 1990-10-17
YU65489A (en) 1991-04-30
WO1989009212A1 (en) 1989-10-05
NO891293L (en) 1989-10-02
ZA892259B (en) 1990-12-28
FI891449A0 (en) 1989-03-28
DK151489D0 (en) 1989-03-29
EP0335381A1 (en) 1989-10-04
JPH02503679A (en) 1990-11-01
GB8907042D0 (en) 1989-05-10

Similar Documents

Publication Publication Date Title
AU565511B2 (en) 2-(imidazol-1-yl and 1, 2, 4-triazol-1-yl)-quinazolin derivatives
AU9075591A (en) N-halochitosans, their preparation and uses
AU3228689A (en) New 2,3,4 - substituted imidazoles and 3,4,5 - substituted 1,2,4, - triazoles, the preparation and use thereof
AU585214B2 (en) Imidazole and 1,2,4-triazole derivatives
AU4671389A (en) Novel fluorine-containing 2-nitroimidazole derivatives and radiosensitizer comprising the same
AU552540B2 (en) Delta 2-1,2,4-triazolin-5-one derivatives
AU5980590A (en) 5-substituted 1,3,4-thiadizole derivatives, their preparation and their use as pesticides
AU1384688A (en) 1,5-substituted 1H-imidazoles
AU579514B2 (en) Fungicidal imidazole and 1,2,4-triazole derivatives
AU3119089A (en) 3,4,5-substituted 4h-1,2,4-triazoles, the preparation and use thereof
ZA89833B (en) 5-substituted ornithine derivatives
AU631448B2 (en) Application aid and the use thereof
AU587646B2 (en) 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
AU3650695A (en) New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
AU5450790A (en) 5-substituted 3-arylisoxazole derivatives, their preparation and their use as pesticides
AU2831392A (en) Substituted 1, 5-pentanediols and processes for the preparation thereof
AU2681888A (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines
AU4121089A (en) 3-pyridylalkyl-4-phenylalkyl-5-mercapto-1,2,4-triazole derivatives
AU6157190A (en) Substituted n-heterocycles, their preparation and their use
AU4718989A (en) 4-amino-5-nitro-1,2,3,6-tetrahydropyrimidines
AU587293B2 (en) 5-heterocyclic-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
AU7495287A (en) 1,2,4-triazol-1-yl methyl and imidazol-1-yl methyl 1,3-dioxolan derivatives
AU6163586A (en) Substituted arydioxolanepyrimidines and aryldiooxanepyrimidines, the preparation thereof and their use as microbicides
AU6438586A (en) 5-naphthyl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
AU624930B2 (en) Pp4-delta, the preparation and use thereof